Ironwood Pharmaceuticals (IRWD) Goodwill & Intangibles (2016 - 2026)
Ironwood Pharmaceuticals' (IRWD) quarterly Goodwill & Intangibles came in at $1.6 million in Q2 2026, down 33.43% year-over-year from $2.5 million in Q2 2025, and down 11.15% quarter-over-quarter from $1.8 million in Q1 2026.
Analysis
Ironwood Pharmaceuticals (IRWD) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Goodwill & Intangibles across 8 years of filings, most recently posting $1.6 million for Q2 2026.
- In Q2 2026, Goodwill & Intangibles fell 33.43% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (down 33.43% YoY), while the FY2025 annual figure was $2.0 million, down 28.67% from the prior year.
- Goodwill & Intangibles came in at $1.6 million for Q2 2026 at Ironwood Pharmaceuticals, down from $1.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $4.1 million in Q2 2023 to a low of $1.6 million in Q2 2026.
- Average Goodwill & Intangibles over 4 years is $2.9 million, with a median of $2.9 million recorded in 2024.
- Year-over-year, Goodwill & Intangibles declined 20.09% in 2024 and tumbled 33.43% in 2026.
- Over 4 years, Goodwill & Intangibles stood at $3.7 million in 2023, then slipped by 22.32% to $2.9 million in 2024, then decreased by 28.67% to $2.0 million in 2025, then fell by 19.95% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $1.6 million in Q2 2026, $1.8 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Ironwood Pharmaceuticals | 669.13 Mn | 590.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.84 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.48 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Sep 30, 2023 | 3.89 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Dec 31, 2019 | 785,000.00 |
| Sep 30, 2019 | 785,000.00 |
| Jun 30, 2019 | 785,000.00 |
| Mar 31, 2019 | 785,000.00 |
| Dec 31, 2018 | 785,000.00 |
| Sep 30, 2018 | 785,000.00 |
| Jun 30, 2018 | 153.74 Mn |